229 related articles for article (PubMed ID: 30371585)
61. Evolution of a Schmorl's Node and a Degenerative Osteophyte on Sequential 68Ga-DOTATATE PET/CT Scans: Potential Pitfalls in Neuroendocrine Tumor Imaging.
Hod N; Levin D; Anconina R; Benkovich E; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2019 Jan; 44(1):e40-e42. PubMed ID: 30418207
[TBL] [Abstract][Full Text] [Related]
62. TeleNEN as a telemedicine model for neuroendocrine neoplasm management in case of Meckel's diverticulum NET.
Kunikowska J; Zemczak A; Górska M; Matyskiel R; Słodkowski M; Łoń I; Chrapko B; Kos-Kudła B; Królicki L
Endokrynol Pol; 2018; 69(3):313-317. PubMed ID: 29952421
[TBL] [Abstract][Full Text] [Related]
63. 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma: Comparison With 18F-FDG.
Derlin T; Sohns JM; Hueper K
Clin Nucl Med; 2017 Apr; 42(4):e210-e211. PubMed ID: 28166150
[TBL] [Abstract][Full Text] [Related]
64. Primary Neuroendocrine Tumor of the Ileostomy Stoma on 68Ga-DOTATATE PET/CT.
Yu L; Braun A; Hansen NJ; Downey RT; Johnson CM
Clin Nucl Med; 2020 Jun; 45(6):463-464. PubMed ID: 32366787
[TBL] [Abstract][Full Text] [Related]
65. Rare Occurrence of Hypergastrinemia Due to Thoracic Neuroendocrine Tumor: Detection and Characterization by 68Ga-DOTATATE PET/CT.
Sampathirao N; Basu S
J Nucl Med Technol; 2016 Sep; 44(3):203-4. PubMed ID: 26848167
[TBL] [Abstract][Full Text] [Related]
66. Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.
Herrmann K; Czernin J; Wolin EM; Gupta P; Barrio M; Gutierrez A; Schiepers C; Mosessian S; Phelps ME; Allen-Auerbach MS
J Nucl Med; 2015 Jan; 56(1):70-5. PubMed ID: 25500825
[TBL] [Abstract][Full Text] [Related]
67. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
[TBL] [Abstract][Full Text] [Related]
68. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
69. 68Ga-DOTATATE Uptake by Cervicothoracic (Stellate) Ganglia.
Berg Z; Koppula BR
Clin Nucl Med; 2019 Oct; 44(10):810-811. PubMed ID: 31306203
[TBL] [Abstract][Full Text] [Related]
70. 68 Ga-DOTATATE Uptake in Well-Differentiated Neuroendocrine Tumor of the External Auditory Canal.
Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Çermik TF
Clin Nucl Med; 2022 Aug; 47(8):e552-e553. PubMed ID: 35439184
[TBL] [Abstract][Full Text] [Related]
71. Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT.
Lu Y
Clin Nucl Med; 2019 Nov; 44(11):914-915. PubMed ID: 31306189
[TBL] [Abstract][Full Text] [Related]
72. 177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.
Demirci E; Kabasakal L; Toklu T; Ocak M; Şahin OE; Alan-Selcuk N; Araman A
Nucl Med Commun; 2018 Aug; 39(8):789-796. PubMed ID: 29912750
[TBL] [Abstract][Full Text] [Related]
73. Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor.
Tatar G; Beyhan E; Arslan E; Ergül N; Çermik TF
Clin Nucl Med; 2023 Feb; 48(2):e71-e73. PubMed ID: 36607376
[TBL] [Abstract][Full Text] [Related]
74. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
75. 68Ga-DOTATATE PET/CT Findings of Cervical Esophageal Neuroendocrine Tumor.
Filizoglu N; Ozguven S
Clin Nucl Med; 2021 Jul; 46(7):e393-e394. PubMed ID: 33630804
[TBL] [Abstract][Full Text] [Related]
76. Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors.
Peter L; Sänger J; Hommann M; Baum RP; Kaemmerer D
Clin Nucl Med; 2014 Aug; 39(8):713-6. PubMed ID: 24561680
[TBL] [Abstract][Full Text] [Related]
77. Schmorl Nodes Can Cause Increased 68Ga DOTATATE Activity on PET/CT, Mimicking Metastasis in Patients With Neuroendocrine Malignancy.
Papadakis GZ; Millo C; Bagci U; Sadowski SM; Stratakis CA
Clin Nucl Med; 2016 Mar; 41(3):249-50. PubMed ID: 26562580
[TBL] [Abstract][Full Text] [Related]
78. 68Ga-DOTATATE PET/CT Incidentally Detects Relapsed Chronic Lymphocytic Leukemia in Patient With Metastatic Neuroendocrine Tumor.
Alabed YZ
Clin Nucl Med; 2023 Feb; 48(2):e78-e79. PubMed ID: 36607378
[TBL] [Abstract][Full Text] [Related]
79. Recurrent/Residual Intracranial Phosphaturic Mesenchymal Tumor Revealed on 68Ga-DOTATATE PET/CT.
Ding J; Wang L; Zhang S; Li F; Huo L
Clin Nucl Med; 2018 Sep; 43(9):674-675. PubMed ID: 30015664
[TBL] [Abstract][Full Text] [Related]
80. 68Ga-DOTATATE Uptake in Ischemic Stroke.
Vallée É; Paquet N; Buteau JP; Turcotte É
Clin Nucl Med; 2018 Jan; 43(1):46-47. PubMed ID: 29135613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
